Xlife Sciences says that Veraxa Biotech is to list as a public company on the Nasdaq Global Market through a strategic merger ...

"Kyle's decades of financial, transactional and operational experience in our industry will make an immediate and positive ...

Investors often rely on the healthcare sector to safeguard their investments. This is because the demand for healthcare services does not vary too much with respect to market conditions and thus the ...

The Fed’s interest rate pause, closed capital markets, the tariff storm, and mass layoffs at the U.S. FDA create a ...

Here are two stocks with buy rank and strong value characteristics for investors to consider today, April 23: Phio ...

Private businesses that give away all profits and also succeed as businesses are scarce; the Newman’s Own food branding ...

Market turmoil may have frozen the traditional IPO pipeline, but German antibody biotech Veraxa is turning to the special ...

Let's see how the company performed during the three months. The post Telix shares rocket 15% on stellar Q1 sales update ...

Neurocrine Biosciences' valbenazine shows promise as an adjunctive therapy for Schizophrenia, with phase 3 data expected in ...

The decision was made at the commission’s 952nd meeting held on Tuesday (22 April), according to a press release signed by BSEC Director and spokesperson Abul Kalam ...

When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.

ORIC Pharmaceuticals is advancing ORIC-114 for 1st-line EGFR/HER2 exon 20 NSCLC, with comprehensive data expected in the 2nd ...